Clover Health Investments, Corp. 2025-2026 Proxy Voting Records

Description as filed by funds: ELECTION OF DIRECTORS: Andrew Toy

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Andrew Toy”): 1,011,117,814 for, 3,423,325 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 33,251,658 for, 159,058 withheld, 39,386 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: ELECTION OF DIRECTORS: Demetrios L. Kouzoukas

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Demetrios L. Kouzoukas”): 1,003,131,251 for, 11,409,888 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 31,384,500 for, 1,987,147 withheld, 78,455 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: ELECTION OF DIRECTORS: Thomas L. Tran

Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Thomas L. Tran”): 996,918,879 for, 17,622,260 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 25,479,280 for, 7,892,321 withheld, 78,501 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025.

Clover Health Investments, Corp.’s own tally for this item (“2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025”): 1,003,065,402 for, 9,811,825 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 42 managers: 33,448,947 for, 926 against, 17 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 138 managers: 33,458,099 for, 937,610 against, 4,191 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

Clover Health Investments, Corp.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026”): 1,188,467,663 for, 2,471,606 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 33,450,094 for, 6 against, 3 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.